News Post

EaseMyTrip invests Rs 90 Cr in two overseas firms; enters medical tourism space

Entrackr · 1m

Online travel aggregator (OTA) platform EaseMyTrip has acquired a 30% stake in Rollins International and a 49% stake in Pflege Home Healthcare to enter the medical tourism market. The board of directors at EaseMyTrip has approved the acquisition of Rollins International (30%) and Pflege Home Healthcare (49%) at a consideration of Rs 60 crore and Rs 30 crore, respectively, the company’s disclosure accessed from the National Stock Exchange shows. According to the filings, the consideration of Rs 90 crore will be paid to Rollins and Pflege in the form of an equity swap i.e. issuance of EaseMyTrip’s shares. “The acquisition is a strategic expansion into the rapidly growing medical tourism sector and align with EaseMyTrip’s mission to offer holistic travel solutions by integrating wellness and healthcare services into its service portfolio as medical tourism.” the company added in the disclosure. Pflege Healthcare is a UAE-based medical tourism provider which offers international patients access to treatments worldwide with partnerships across top-tier medical institutions and leading hotel chains. Rollins International is a subsidiary of Singapore-based RHA Holding which focuses on wellness, healthcare, and consumer products such as gluten and lactose-free food products, allergen-free health supplements, wellness therapies and treatments. Earlier this month, EaseMyTrip’s board also approved the proposal for the manufacturing of electric buses. Over the years, the company expanded its portfolio through the acquisition of several firms in the travel and hospitality sectors, including Guideline Travels Holidays, TripShope Travel Technologies, and Dook Travels last year. The Nishant Pitti-led firm recorded a 6.8% quarter-on-quarter decrease in its revenue to Rs 152.6 crore in the first quarter of the ongoing fiscal year as compared to Rs 164 crore in Q4 FY24. A slight decline in scale led EasyMyTrips’s profits to down by 13% to Rs 33.92 crore in the same period.